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Abstract
Mycobacterium avium subsp. paratuberculosis is the causative agent of Johne’s disease in ruminants. As an infectious
disease that causes reduced milk yields, effects fertility and, eventually, the loss of the animal, it is a huge financial
burden for associated industries. Efforts to control MAP infection and Johne’s disease are complicated due to
difficulties of diagnosis in the early stages of infection and challenges relating to the specificity and sensitivity of
current testing methods. The methods that are available contribute to widely used test and cull strategies,
vaccination programmes also in place in some countries. Next generation sequencing technologies have opened
up new avenues for the discovery of novel biomarkers for disease prediction within MAP genomes and within
ruminant microbiomes. Controlling Johne’s disease in herds can lead to improved animal health and welfare, in
turn leading to increased productivity. With current climate change bills, such as the European Green Deal,
targeting livestock production systems for more sustainable practices, managing animal health is now more
important than ever before. This review provides an overview of the current knowledge on genomics and
detection of MAP as it pertains to Johne’s disease.
Introduction
Mycobacterium avium subsp. paratuberculosis and Johne’s
disease
Mycobacteria, which belong to the phylum Actinobac-
teria, are Gram-positive, acid-fast organisms that include
a number of relevant human and animal pathogens such
as Mycobacterium leprae, Mycobacterium tuberculosis
and Mycobacterium avium subsp. paratuberculosis
(MAP). MAP, the focus of this review, is a slow-growing,
rod-shaped, non-spore-former, with a unique complex
lipid cell wall structure [1]. It is this complex cell wall
structure that is in part responsible for its persistence in
the environment and in the host. MAP is an intracellular
parasite of animals [2] and, paradoxically, as the growth
rate of the microorganism decreases, its pathogenicity
increases [1]. Unlike some other mycobacteria, MAP is
unable to synthesize mycobactin, a siderophore
employed to obtain iron from environmental sources. As
a result, MAP cannot replicate outside of the animal
host without mycobactin supplementation. This Myco-
bacterium is the causative agent of Johne’s disease (JD)
in ruminants, a chronic enteritis, causing weight-loss
and diarrhoea, increased susceptibility to other diseases,
and economically impacts farmers worldwide [3].
MAP is most commonly transmitted during neo-natal
life, after transmission via the oral route. Infected ani-
mals can be classified into a number of distinct stages of
silent, subclinical (greatest threat to eradication and con-
trol), clinical and advanced stages of disease. These cat-
egories are based on the presence and severity of clinical
signs, the rate of environmental shedding and the likeli-
hood of detection with current MAP diagnostic methods
[4]. Animals that are infected with MAP, but have no
evidence of disease and cannot be detected with current
diagnostic methods, are said to be in the silent stage [5].
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Subclinical animals show an immune response, shedding
low but infectious levels of the pathogen. Clinical and
advanced stages are represented by diarrhoea and
weight-loss to eventual death due to dehydration and
cachexia [6]. It is important to distinguish between in-
fection and disease as infection does not always equate
to disease. The disease results in a decrease in milk yield
(reported in both clinical and sub-clinical stages of infec-
tion), adverse effects on reproductive performance and
increased culling rates.
The “iceberg phenomenon” allows the generation of
estimates for JD prevalence. It is driven by the theory
that there is an underestimation of prevalence and that
the true prevalence in infected herds is greater than the
apparent prevalence [7]. This was first described by
Whitlock and Buergelt [4], (1996) where they reported
that for every animal in the advanced stage of disease, it
is assumed that there are one to two in the clinical stage,
four to eight in the subclinical stage, and ten to fourteen
in the silent stage. More recent advances in mathemat-
ical modelling have indicated that the number of sub-
clinical shedding animals is higher than animals in the
silent stage [7]. It is important to note that only 10–15%
of animals that are infected progress to clinical disease,
suggesting that most calves successfully clear the infec-
tion or they are resistant to the disease [8].
After oral ingestion of the pathogen, the tissue of the
intestinal mucosa and submucosa of the ileum and je-
junum, or more specifically the M cells of the Peyer’s
patch, is targeted by MAP, allowing the subsequent inva-
sion of, and multiplication within, intestinal macro-
phages. Gross pathological changes in cattle with JD
include thickening and corrugation of the intestinal wall
(resulting in an inability to absorb nutrients), dilation of
lymphatic vessels and enlargement of mesenteric lymph
nodes [9]. The bacilli can remain viable for extended pe-
riods of time in water, soil and faeces [10, 11], but can
survive in urine and silage for much shorter periods due
to the challenges of enduring high ammonia levels and
low pH environments [11, 12].
Strains of MAP are notoriously difficult to isolate,
often taking months to grow in pure culture, thereby
making the detection and diagnosis of JD challenging.
Upon histopathological examination, cases display
granulomatous inflammation, primarily in the ileum and
draining lymph nodes. Other sites along the gastrointes-
tinal tract may also be involved. Clinical signs of the dis-
ease are not observed until around the third lactation
[13, 14] or between 2 and 5 years after initial infection
and can be characterised by loss of body condition, de-
crease in milk production and scour.
The importance of MAP with respect to the livestock
sector in terms of economic losses (including reduced
milk production, increased somatic cell counts,
increased incidence of clinical mastitis, reduced fertility
and increased susceptibility to other diseases) and wel-
fare is further amplified by the potential zoonotic trans-
mission of the bacteria [15, 16]. The economic impact of
paratuberculosis in a cattle herd will depend on the
number of animals affected, infected and infectious [16].
Animal health has also become a talking point in climate
change mitigation strategies such as the European Green
Deal as life cycle analysis suggests that greenhouse gas
emissions in dairy cows with JD is up to 25% higher than
healthy animals [17]. MAP has also been associated with
a number of autoimmune diseases [1] in humans, in-
cluding multiple sclerosis [18], type 1 diabetes [19] and
Blau syndrome [20], with Crohn’s disease (CD) receiving
the most attention due to the similarity of the sympto-
mology of CD to JD and debate in relation to the poten-
tial for zoonotic transmission. MAP was first implicated
in CD in 1913. CD is a complex immune-mediated
chronic enteritis characterized by chronic gastrointes-
tinal inflammation [21], with the gut microbiome being
thought to be highly involved in pathogenesis with a re-
duced diversity and imbalance considered characteristic
of the disease [22–24]. However, it is still unclear if in-
flammation is caused by specific taxa and the causative
mechanisms have yet to be defined. In recent years,
MAP has again been suggested as a possible cause of the
disease as some studies have found that MAP strains
can be cultured from the peripheral mononuclear cells
from 50 to 100% of patients with CD [25, 26]. However,
notably, MAP has also been found in healthy individuals
with no clinical signs of infection [27, 28] and, although
the zoonotic potential cannot be ignored, there is not
yet enough evidence to either support or oppose an im-
pact of MAP on public health [29], as Koch’s postulates
have been fulfilled with respect to the involvement of
MAP in ruminant, but not for human, disease.
Despite the lack of conclusive evidence to date, the po-
tential for zoonosis is a concern. It is thus notable that
MAP has been detected in milk from domestic animals
using a number of detection methods [30–32]. MAP has
been reported in raw milk in developed countries in-
cluding, Czech Republic (2%), Ireland (0.3%), UK (6.9%),
USA (0–28.6%) [33]. There is debate as to how well pas-
teurisation inactivates MAP [34–36], but it is important
to recognise that the pasteurisation conditions used
across studies vary considerably.
In this regard, rapid detection of mycobacteria from
different matrices is necessary in order to prevent dis-
ease spread. Optimising tests, including standardisation
and a capacity to work with small amounts of biological
material where necessary, are all important develop-
ments that can be further improved. Utilising the micro-
biome in order to determine microbial biomarkers of
exposure or infection may be pivotal for the control and
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prevention of JD going forward. As intestinal inflamma-
tion is one of the major traits of MAP infection and the
resulting JD [3], having a major impact on the compos-
ition and functionality of the gut microbiome, it affects
the host enormously in terms of nutrient absorption.
The intestinal wall is thickened and the mucosal surface
has thick, closely packed transverse folds [37]. The mu-
cosa between folds may be reddened by congestion and
ulceration. Lesions are seen at the site of infection in the
gut, towards the terminal end of the ileum.
Prevalence and distribution
Since the disease was first identified in the Netherlands,
JD has been detected in all countries with ruminant pop-
ulations, in both wild and domestic animals. The preva-
lence and distribution of JD varies from country to
country. Estimates of true herd prevalence in Europe
vary from 31 to 71% in The Netherlands [38], 47% in
Denmark [39] and 18% in Belgium [40]. In Ireland, for
example, prevalence of JD remains relatively low in com-
parison to other countries but has risen [41] as a conse-
quence of Ireland joining the Single European market in
1992. This allowed the free movement of animals be-
tween European countries and resulted in the abandon-
ment of pre-import testing and post-import quarantine.
Environmental sampling is a quick way to determine
the presence of MAP in a herd without having to sample
individual animals. However, this method is not sensitive
enough for animals kept on open pastures and may only
be used to detect the agent in housed dairy systems [42].
In a survey carried out by Good et al. (2009), it was
found that, in Ireland, of over 20,000 animal samples
tested, just 201 were classified as ELISA positive. 21.4%
of herds had one or more ELISA positive animal, while
only 6.4% had more than one ELISA positive animal
[41]. The true prevalence of all animals tested in this
study was found to be 2.86%.
Management practices and infection control
MAP is present in the environment and can be found
ubiquitously on farms with MAP positive herds. In a
comprehensive survey on management practices by [43],
it was found that many practices employed on Irish dairy
farms impact on the transmission of JD. Although it has
been suggested that a pasture-based system may lessen
the prevalence of JD due to less exposure to contami-
nated faeces, practices such as importing animals and
manure from other farms, pooling colostrum, using calv-
ing areas for more than one calving and housing sick an-
imals in the calving area all contributed to higher
increase in JD transmission. In a study describing calf to
calf transmission, it was found that infection occurred
due to exposure of infectious pen-mates to contact
calves [44]. The study found that all animals were faecal
culture positive (however, shedding stopped after ani-
mals were housed individually), 50% of contact exposed
animals had MAP positive tissue results and 36% had
evidence of a cellular immune response. Although the
sample size of the study was small (n = 32), it did involve
an intensive sampling regimen with 3 sampling time
points per week for faecal samples and once weekly for
blood and environmental for the course of the 3-month
trial.
Large herd sizes are also associated with increased
MAP infection, and since the removal of quotas in
Ireland in 2015, herd sizes have continued to increase,
thus threatening to impact the prevalence of JD. Al-
though there are not yet studies to show that this is the
case in Ireland, it has been well documented that an in-
creased herd size has higher incidence of the disease
[45]. A thorough examination of prevalence estimations
have been examined between 2013 and 2014 [46], there-
fore, there is substantial data available to carry out a
follow-up study post quota removal. In a comprehensive
review by Whittington et al. (2019), a significant associ-
ation between herd size and herd level prevalence was
found, where, for every log increase in herd size, the
odds of a country having a higher category of prevalence
increased by 9.7% [47]. Examples of the effects of inten-
sive farming on prevalence of MAP can be seen globally,
with many studies examining factors which promote an
increase in MAP positive herds. In a study carried out
on 148 Canadian dairy farms, it was found that herds
with > 200 cows were found to be more likely to be fae-
cal culture, MAP positive and remained MAP positive
for a number of years, than herds with < 51 cows [48]. It
was also found that herds with > 200 cows had 3.54
times higher likelihood of a positive test in environmen-
tal samples than herds of < 50, again suggesting intensifi-
cation has an impact on prevalence [49]. The level of
intensity and its impact on herd and animal sero-
prevalence of MAP was also examined by Liu et al.
(2017) on farms in Northwest China and it was found
that intensive farming (described here as herds with >
200 animals with no access to pasture) had a relatively
higher risk of being infected with MAP than free ranging
herds [45]. Multivariate logistic regression showed a sig-
nificant association on the sero-positivity of goats from
Spanish herds and intensive productions systems [50].
Ultimately, intensive production systems have a higher
density of animals that are in close proximity to each
other, thereby favouring horizontal transmission.
Control programmes have been developed and imple-
mented in a number of countries worldwide in order to
prevent the spread of the JD. Countries differ in the
methods of control employed, with a number of pro-
grammes focusing on MAP-positive herds being tested
regularly and the culling of infected animals. Other
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countries focus on MAP-negative herds and trying to
keep those herds negative [42]. As there are no effective
cures yet developed for JD, these control programmes
are employed in order to try and eradicate the disease.
Furthermore, the current vaccines for MAP compro-
mises the diagnosis of bovine tuberculosis in cattle [5,
51]. JD vaccination programmes have been implemented
in several countries including the USA, which previously
used the commercially available vaccine Mycopar®, but
have now been discontinued (2019). This is due to a
number of short-comings with this particular vaccine in-
cluding lesions at the site of inoculation and the interfer-
ence with bovine TB (bTB) diagnostics. Additionally, the
vaccine failed to completely prevent faecal shedding of
the pathogen in a number of recent studies [52, 53].
Gudair® (Zoetis Inc.) is available in Australia and the UK
for ovine Johne’s disease with Silirum® (Zoetis Inc.) avail-
able for bovine Johne’s disease (Australia only). Australia
has an advantage in relation to vaccination programmes
for JD in that bovine TB has already been successfully
eradicated. Precautionary information available infers
that the vaccine may have potential effects on false posi-
tive results to bTB testing and therefore would not be
suitable in countries where M. bovis is still a problem.
There have been 146 vaccine trials or studies conducted
across a number of different countries which have been
shown to positively impact the prevalence of disease in
those countries [54]. Other countries, like Sweden for
example prohibit by law the use of vaccination for JD
[55]. The development of live attenuated vaccines, such
as those examined by Shippy et al. [53], with an accom-
panying assay to differentiate between animals infected
with M. bovis or MAP and vaccinated animals (DIVA),
may offer a more robust and effective vaccination
programme that may be applicable in countries that
have not yet eradicated bTB. In countries where vaccin-
ation is not employed, the control of MAP infection is
more difficult due to the fact that the pathogen can sur-
vive in ambient conditions for 8 months [56], for 19
months in water at 38 °C and in a desiccated state for up
to 47months [57]. This, combined with the slow pro-
gress of the disease, the slow growth of the bacteria and
the sensitivity and specificity of current diagnostic
methods, makes JD extremely difficult to eradicate. In a
comprehensive review by Barkema et al. (2017), the
many knowledge gaps that hamper the prevention and
control of JD were highlighted [42]. The review identi-
fied many areas that need to be addressed in order to
combat the disease including an assessment of the long
term efficacy of control programmes, comparisons of
MAP prevalence over time in the same regions, examin-
ation of the effect of mixed genotype infections and su-
perinfections and the distribution of MAP genotypes,
among many other areas of potential improvement.
Diagnosis and detection of MAP
Effective control of animal diseases is dependent on
rapid and accurate detection of pathogens using sensitive
and specific diagnostic tests. There is a broad variety of
methods available for the detection, identification and
characterisation of pathogenic microorganisms present
in a range of biological environments including blood,
milk and faeces. These methods include microscopy,
histopathological, isolation of pathogen from environ-
mental samples, and immunological and molecular
based diagnostics. These methods vary widely and each
has their own individual benefits, in terms of cost, repro-
ducibility sensitivity, specificity and time taken to pro-
duce results. Environmental testing is often used for
herd level detection, where a slurry sample (urine, faeces
and often, effluent) is used for MAP detection. This type
of sampling may hamper the accuracy of the testing as a
slurry mix provides a hostile environment for MAP sur-
vival. Hahn et al. (2017) examined the use of different
diagnostic methods for the detection of MAP on boot
swab and liquid manure samples [58]. Although the
main aim of the study was to examine qPCR protocols
for the detection of MAP, the group identified that li-
quid manure was negatively impacting on qPCR-based
analysis, with boot swabs analysis being more represen-
tative of the infection status of the herd. The authors of
this study also identified the dilution of MAP in the fae-
cal slurry and/or the presence of effluents and urine that
contribute to PCR inhibition as being factors in false
negative results.
Detection of MAP in cattle
Culture
Faecal culture is considered the “gold standard” in JD
diagnostics [59]. It is relatively inexpensive and the speci-
ficity is considered to be almost 100%. However, this
method relies on the growing of microbes, which is prob-
lematic as MAP is the slowest growing subspecies from
the family Mycobacteriaceae, taking from 8 to 12 weeks
for strains to grow. The Cornell double incubation decon-
tamination method is often used, where a pre-incubation
of the sample is carried out in brain-heart infusion
medium to initiate the growth of bacteria and fungal
spores. The second step involves the addition of antibi-
otics [60]. Furthermore, if animals are shedding low levels
of MAP or are intermittently shedding the bacteria, sensi-
tivity of culture can be low, ranging from 23 to 70% in in-
fected, infectious and affected animals [61].
Liquid media of choice is typically Trypic Soy or Mid-
dlebrook supplemented with Oleic Albumin Dextrose
Catalase (OADC) and mycobactin. Confirmation tests
include the Ziel-Neelson staining method. This staining
technique is used to stain acid-fast bacilli with an intact
cell wall. Used as part of post mortem examinations, this
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test is cheap and fast, but cannot differentiate between
mycobacterial species. The sensitivity of faecal culture is
~ 70% at the clinical stage of infection, but much less
(23–29%) at the sub-clinical stage, where MAP is shed
intermittently and in low numbers [62].
Isolation of MAP from the faeces of infected animals
is still the most reliable method for detecting infected
animals due to its high specificity. However, long incu-
bation times and variations in sensitivity mean that this
method also has its disadvantages. These variations may
be a consequence of media type and methods of prepar-
ation i.e. commercial versus laboratory-made media, in-
creasing inter-laboratory variability [63].
Molecular epidemiology of Mycobacterium avium complex
MAP is a subspecies of the Mycobacterium avium com-
plex (MAC) along with a number of other opportunistic
pathogens associated with both humans and animals
(Fig. 1). Although genetically similar, these pathogens
are distinct with respect to their hosts and pathogenic
characteristics. The MAC consists of four subspecies,
namely Mycobacterium avium subsp. hominissuis
(MAH), Mycobacterium avium subsp. avium (MAA),
Mycobacterium avium subsp. salvaticum (MAS) and
Mycobacterium avium subsp. paratuberculosis (MAP).
Research has shown that MAH is an environmental op-
portunistic pathogen found in humans and swine glo-
bally [65]. Soil and water are considered the natural
reservoirs for this pathogen and, although isolated from
a number of different animals, this does not confirm
zoonotic potential [66]. MAH is considered the clinically
most important of the MAC subspecies for humans [67],
historically causing morbidity in acquired immunodefi-
ciency syndrome (AIDS) patients. MAA causes a TB–
like disease in birds, the main reservoir of the subspecies
[68]. Avian TB is a chronic wasting disease, although in
many cases is asymptomatic. Infection is thought to
occur through fecal-oral transmission of contaminated
faeces by susceptible animals. MAS is taxonomically
close to MAA, causing a TB-like disease that occurs
mainly wood pigeons but has also been reported in
mammals [69, 70].
MAP itself can be further subdivided into Cattle Type
and Sheep Type, each of which can be further divided as
illustrated in Fig. 1. MAP is the only MAC subspecies
that exclusively infects the gastrointestinal tract [71].
It is hypothesised that MAP originally evolved from
MAH, which is the most genetically variable subspecies
within MAC [72]. The proposed biphasic evolutionary
model includes the idea of a proto-MAP, which evolved
following the acquisition of 7 large sequences and the
loss of 1 large sequence [65, 73]. The second phase,
which involved the subdivision of the sheep and cattle
type lineages, emerged independently following the
lineage specific genomic deletion events. Alexander, Tu-
renne and Behr (2009) examined the insertion and dele-
tion events that shaped MAP as a subspecies, focusing
on 25 large sequence polymorphisms, which are gen-
omic regions present in some Mycobacterium avium
(MA) strains and absent from others [73]. Sixteen of the
Fig. 1 Nomenclature of Mycobacterium avium subsp. paratuberculosis (Adapted from [64]). There are two major groups of strains; Sheep-type, or
Type S, and Cattle Type, or Type C, and an “intermediate” Type III, a sub-type of Type S. Type B is a subtype of Type C and is typically isolated
from Bison
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regions examined were specific to MAP, with a number
of the regions supporting the existence of lineage spe-
cific genovars, cattle type and sheep type. The LSPA20
and “deletion 2” regions were absent from strains of the
sheep lineage only. Similarly, MAV-14, LSPA18, LSPA4-
II, and a region of the GPL cluster were absent from all
strains of the cattle lineage [73]. Another notable fea-
ture is that the MAP genome contains multiple copies
(14–18) of a species-specific insertion element, IS900,
that can be used for diagnostic purposes to, for ex-
ample, detect the presence of the microorganism in
faecal material following DNA extraction and PCR.
This 1451 bp element is considered to be unique to
MAP. The reference strain for MAP is K-10, a Type
II (cattle type) strain, which a single circular chromo-
some consisting of 4,829,781 base pairs, encoding
4350 ORFs, and a G + C content of 69.3% [74]. The
reference strain has 17 copies of the aforementioned
IS900 species specific insertion element. It is also
worth noting that F57, a single copy insertion elem-
ent, is also used for detection purposes [75, 76].
Genetic diversity of MAP
Understanding the differences between strains of MAP
is important in establishing how such difference might
influence both the development and transmission of dis-
ease [77]. All microbial genomes are subject to plastic
changing over time due to spontaneous mutations and
in response to changing selective pressures within the
microenvironments they inhabit. Understanding the gen-
etic variability and, in turn, the molecular epidemiology
of different strains of MAP can greatly improve our un-
derstanding of their influence on onset and severity of
infection and also transmission patterns, enabling gov-
ernments to employ more efficient control measures, tai-
lored to each country.
In contrast to MAH, MAP has a relatively low genetic
heterogeneity [64]. In total, 75% of the MAP genes have
counterparts in TB, with 39 predicted proteins that are
unique to MAP [3]. The genome possesses a high redun-
dancy rate due to gene duplication, particularly for those
involved in lipid metabolism and the redox process. As
discussed earlier, there are two major groups of strains;
Sheep-type, or Type S, and Cattle Type, or Type C, and
an “intermediate” Type III, a sub-type of Type S [77],
with several strain typing techniques available to cat-
egorise these isolates. Of these methods, it has been sug-
gested that genome wide SNP detection provides
considerable resolution between strains [78]. In contrast,
although Mycobacterial Interspersed Repetitive Unit-
Variable Number Tandem Repeat (MIRU-VNTR) can
differentiate between Type C and Type S, it provides
limited resolution between isolates within these lineages
[78]. Regardless, molecular typing techniques have
provided a valuable insight into the evolution, genetic di-
versity, interspecies transmission and inter and intra
herd infection [59]. In one instance, de Kruijf et al. [79]
examined a large collection of MAP isolates from the
Republic of Ireland using MIRU-VNTR, and showed
that among the isolates used, there were four distinct
INMV group classifications (MIRU-VNTR patterns) re-
ported from 53 herds. The most dominant groups found
were INMV 1 and INMV 2, accounting for 98.2% of iso-
lates analysed and highlighting a low genetic diversity
among Irish isolates. This observation was consistent
with another by Douarre et al. [80] also from Irish iso-
lates. In a similar study carried out in German cattle
herds, a high genetic diversity among MAP strains was
apparent [81]. More recently, Bryant et al. (2016) ex-
plored the phylogenomic relationship between strains of
MAP found in a range of different countries from a
range of different hosts [78]. This study found that using
whole genome sequencing (WGS) in conjunction with
MIRU-VNTR led to better resolution. It was also found
that sequencing of MAP isolates from patients with in-
flammatory bowel disease showed that these do not
comprise a distinct strain type and cluster with Type C
cattle isolates [78].
Molecular methods
Molecular methods have been used for decades in
microbiology research and have increasingly improved
since their advent. They are rapid, sensitive and spe-
cific. As there are certain limitations associated with
traditional microbiology techniques, a great deal of
this can be overcome through the use of molecular
methods. They are used to support and complement
conventional methods. Current applications of mo-
lecular methods in human and veterinary medicine
include the rapid use of non-culturable agents and
antimicrobial drug susceptibility testing. These ap-
proaches offer a number of different protocols for the
detection of disease caused by difficult to culture,
slow-growing microbes. Results are obtained more
rapidly, thus enabling prompt disease diagnosis. Amp-
lification techniques such as polymerase chain reac-
tion (PCR), real-time polymerase chain reaction
(qPCR) or nucleic acid sequence-based amplification
can be used for genotyping and quantification and
can also be used in conjunction with culture tech-
niques for confirmation of culture. Although these
methods have significantly contributed to our under-
standing, they can be subject to error associated with
cross contamination, ineffective DNA extraction pro-
tocols and the presence of inhibitors leading to false-
positive/negative results. Cunha and Inácio (2014)
have detailed a SWOT analysis of molecular diagnos-
tic technologies [82].
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DNA extraction
DNA extraction methods affect the recovery of different
microbial communities from environmental samples.
Faeces represents one of the most complex matrices for
microbial DNA isolation due to the presence of DNA
from a number of other sources, namely food and the
host itself, but also inhibitors which have consequences
for PCR amplification and NGS preparation [83]. In
order to apply PCR methods and the aforementioned se-
quencing approaches for microbiome analysis, the ex-
traction of good quality DNA from faecal samples is
pivotal for microbiome analysis [84]. A number of stud-
ies have compared a wide variety of commercial kits and
protocols in order to determine the most sensitive and
specific kit for carrying out molecular detection of MAP
[84–87]. Extraction of genomic DNA from MAP is diffi-
cult due to its unique lipid rich cell wall, mentioned earl-
ier in this review, making it difficult to lyse. This unique
cell wall consists of a peptidoglycan layer, surrounded by
a hydrophobic arabinogalactan-peptidoglycan-mycolic
acid layer [71]. This is further surrounded by a second
layer containing lipopentapeptide (L5P). A successful
DNA extraction can be defined as one that results in
high quantity and quality DNA. Therefore, the choice of
suitable DNA extraction methods are pivotal in molecu-
lar research. Choice depends on a number of factors in-
cluding time-efficiency, cost-effectiveness, the type of
biological sample, collection and storage requirements
[88, 89]. The use of mechanical disruption, such as
bead-beating and/or sonication, can be used to increase
the concentration of DNA achieved with sonication be-
ing shown to enrich mycobacterial DNA [90]. However,
this shears background bacteria leaving it an unsuitable
lysis method for microbiome analysis. The use of a pre-
treatment enzymatic incubation to weaken the mycobac-
terial cell wall has been shown to increase in MAP DNA
extracted. Lysis buffers, a heat lysis step and mechanical
disruption being are necessary for the extraction of
DNA from this difficult pathogen [76, 91]. Procedures
for the removal of contaminants and DNA precipitation
within extraction methods also play an important role in
quality and quantity. Inefficient removal of contami-
nants, such as humic acids and complex polysaccharides,
may result in PCR inhibition. DNA extraction efficiency
has been compared using commercially available DNA
extraction kits based on both magnetic separation and
silica columns [87]. It was found that silica column
based methods were superior to magnetic separation
methods for both milk and faecal microbial DNA isola-
tion. Efficacy was determined by qPCR. De Grossi et al.
(2020) used a QIAamp DNA minikit following resuspen-
sion of faecal material in DEPC water [92]. This method
did include mechanical disruption, which may be neces-
sary for lysis of MAP cells. Bauman et al. (2016) [93]
used the Tetracore MAP DNA extraction kits prior to
decontamination protocols set out in a separate kit from
the same company. The kit involves the use of mechan-
ical disruption to lyse MAP cells. (Ramovic et al. 2019)
[94] targeted the IS900 sequence using the LSI VetMAX
kit (LSI, Lissieu, France) and the spin column Qiagen
DNA mini kit following double incubation. (Taniguchi
et al. 2020) [95] used Johne-spin (FASMAC, Atsugi,
Japan).
From our brief review of the recent literature it was
found that commercial kits using mechanical disruption
and silica column purification, due to their high binding
affinity for DNA, are preferred for DNA isolation from
complex matrices such as faeces and milk.
qPCR
Quantitative PCR is now a well-established method for
the detection, quantification and typing of microbial
agents in clinical and veterinary diagnostics and food
safety [96]. The main advantage of qPCR is that it can
provide fast and high throughput detection of target
DNA from complex biological matrices. This method al-
lows for the quantification of targeted sequences where
the number of amplification cycles required to generate
a product correlates with the copy number of a target
sequence.
The use of targeted regions of MAP such as the previ-
ously mentioned multi-copy IS900 is commonly used in
molecular MAP diagnostics, detecting MAP in culture,
faeces, tissue, milk, milk powder and cheese. This is
followed by f57, a single copy gene [63]. qPCR ap-
proaches have also been employed that target IS1311,
mbtA gene, IS_MAP04 and IS_MAP02 [59, 97]. In a re-
cent study carried out by Butot and colleagues, it was
found that IS900 targets were preferred in terms of sen-
sitivity and presented with the lowest levels of variability
between laboratories, for the detection of MAP in milk
in comparison to f57 and phage based techniques. A
number of commonly used primers can be found in
Table 1. They state this is a consequence of the use of
standardised reagents using commercial kits that are
available for DNA extraction and qPCR assays. Digital
PCR (dPCR), also known as third generation PCR, is said
to be more precise and predict absolute numbers of mi-
crobes shed in faeces and is also resistant to inhibitors.
Furthermore, a calibration curve is not necessary to pro-
vide a copy number, an issue that is often faced with
qPCR. However, similar hurdles may be encountered
during optimisation including choice of master mix,
template properties and positioning of primers using the
BioMark dPCR system. Nonetheless, dPCR may be an al-
ternative to qPCR in the validation of tests and bio-
markers. Such investigations have been carried out by
Devonshire et al. (2015) with regards to M. tuberculosis
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[102]. More recent advances in rapid disease identifica-
tion using PCR-like, lab-on-a-chip, portable devices are
paving the way for cheaper and faster disease diagnosis.
TriSilix, a disposable, silicon-based integrated Point-of-
Need transductor, has been tested to quantitatively de-
tect MAP using IS900 primers, with the limit of detec-
tion equivalent to a single bacterium [103]. In that
instance, DNA was extracted from pure cultures of
MAP K-10 reference strain but further tests are needed
with more complex matrices such as milk and faeces
that contain inhibitors that may hamper results.
Novel bacteriophage based methods
Bacteriophage, i.e., viruses that infect bacteria, can be
used as tools for the detection of bacterial pathogens
and offer a non-antibiotic method to improve animal
health and food production. These viruses have co-
evolved with their bacterial hosts to recognise and infect
their target cells with extraordinary specificity that can
be harnessed for rapid detection of MAP [104]. This is
the due to the fact that the rapid, complete infection
cycle of virulent phage can take just 1–2 h. Phage/phage
lysis can be used in many ways to detect bacterial patho-
gens. This includes using intracellular components as
markers to measure the lysis event and, in turn, the
number of pathogen cells initially present. Adenosine
triphosphate (ATP) is the intracellular marker most
widely used for determination of bacterial numbers in a
sample through cell lysis. Impedance or conductivity can
also be used as a pseudomarker. Phage amplification as-
says can also be used, which involves the use of unmodi-
fied phage particles to generate and enumerate plaques
within a bacterial lawn. The detection of Mycobacterium
tuberculosis in human sputum samples, by using a lawn
of fast-growing Mycobacterium smegmatis as an indica-
tor, which constitutes the basic principle of the FastPla-
queTB and FastPlaque-Response (for detection of
rifampicin-resistant Mycobacteria) tests, represents an-
other interesting approach [105]. This assay has also
been reported to be applicable to the detection of MAP
upon optimisation [106]. The assay is coupled with
plaque PCR testing for the presence of signature ele-
ments and allows to detection of viable cells [104]. The
Actiphage® test developed by Swift et al [107], which
uses the above principles [108], has been commercialised
by PBD Biotech with a similar method recently devel-
oped by [101]. Phage based assays can also be coupled
with peptide-mediated magnetic separation for MAP cell
capture [109, 110]. However, the protocols are often
complex and considerable training is required for accur-
ate and reproducible results. Although phage based as-
says have the benefits of being rapid in comparison to
more traditional methods, there are issues that may be
encountered when attempting to isolate phage from a
given environment. In order to generate phage, isolation
of the host target bacteria is needed. This may be prob-
lematic when dealing with a slow-growing pathogen
such as MAP. An avirulent MAP mutant or closely
Table 1 Primer pairs, targets and conditions commonly used for MAP detection




J5A (Forward 5′-ATGTGGTTGCTGTGTTGGATGG-3′) J5B
(Reverse 5′-CCGCCGCAATCAACTCCAG-3′)
IS900 298 94 °C for 5 min; [94 °C for 30 s, 66 °C for 30 s, and 72 °C for 1
min] × 4 cycles; [94 °C for 30 s, 64 °C for 30 s, and 72 °C for 1
min] × 4 cycles; [94 °C for 30 s, 62 °C for 30 s, and 72 °C for 1
min] × 4 cycles, [94 °C for 30 s, 58 °C for 30 s, and 72 °C for 1




IS900 145 37 °C for 10 min, followed by initial denaturation at 95 °C for




F57 147 37 °C for 10 min, followed by initial denaturation at 95 °C for




IS900 229 1 cycle at 94 °C for 5 min and 20 cycles at 94 °C for 45 s,
58 °C for 1 min, and 72 °C for 2 min, followed by a final
extension cycle at 72 °C for 7 min
[100]
f57_F (Forward 5′-TTG GAC GAT CCG AAT ATG T-3′)
f57_R (Reverse 5′-AGT GGG AGG CGT ACC A-3′)
F57 254 1 cycle of pre-incubation: 95 °C for 10 min. Followed by 40
cycles of 95 °C for 10 s, 60 °C for 10 s and 72 °C for 20 s
[75, 97]
mbtA_F3 (Forward 5′–CTC CCG CAA CTC GGT CAC–
3) MAP2179_R3 (Reverse 5′–CAC AGC CAG GTG TGA
AAG–3′)
mbtA 307 1 cycle of pre-incubation: 95 °C for 10 min. Followed by 40
cycles of 95 °C for 10 s, 60 °C for 10 s and 72 °C for 20 s
[97]
P90 (Forward 5′-GAA GGG TGT TCG GGG CCG TCG
GCC TTA GG- 3′) P91 (Reverse 5′-GGC GTT GAG GTC
GAT CGC CCA CGT GAC-3')
IS900 394 4 min of initial denaturation at 95 °C, 37 cycles of 95 °C for
30 s, 59.5 °C for 30 s and 72 °C for 30 s, followed by a final




IS900 N/A 95 °C for 10 min, followed by 40 cycles of 95 °C for 30 s, 58 °C
for 1 min and 72 °C for 1 min
[28, 31,
101]
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related fast growing, non-pathogenic host could also be
considered.
Host immunological response to MAP exposure; ELISA
and Interferon gamma
An immunological response to MAP can be detected by
measuring host antibody production for which a number
of methods are available. However, they are only at their
most sensitive in the late stage of infection when anti-
body production is highest. The enzyme linked immuno-
sorbent assay (ELISA) is used to detect antibodies or
infectious agents in a sample. In the case of JD, it exam-
ines the host response to MAP infection. However, the
specificity and sensitivity of the test varies considerably,
with sensitivity ranging from 15% in subclinical cases
(due to low antibody production) to over 90% in clinical
cases [111] ELISA of milk and serum samples is rou-
tinely used when screening herds for MAP [111].
Gamma interferon (IFN-γ) also provides an insight into
cell mediated immunity against bovine tuberculosis and
paratuberculosis. IFN-γ is a cytokine released by T-
lymphocytes following the stimulation of the immune
system by an antigen. Blood samples are taken from the
animal and incubated in the presence of test antigens
followed by a quantification of IFN-γ using ELISA. A
difficulty associated with this type of testing is the pres-
ence of shared antigens with bovine tuberculosis and
other members of the Mycobacteriaceae, causing ani-
mals which are not infected with paratuberculosis to
cause false positive reactions. An investigation into this
interference with test specificity was carried out by Ken-
nedy et al. (2014). In the study, it was found that animals
that were tested for bovine tuberculosis using the intra-
dermal cervical comparative test interfered with JD
ELISA diagnostics, resulting in a number of false posi-
tives. The sensitivity of serum ELISA is 40–87% in cattle
with clinical signs, 24–94% in cattle with no clinical
signs but shedding MAP and 7–22% in cattle with no
clinical signs and no shedding of the organism. The sen-
sitivity of this test is dependent on exposure to environ-
mental mycobacteria, concurrent infection with
Mycobacterium bovis, intradermal tuberculosis testing
and MAP vaccination. It was also found that the admin-
istration of purified protein derivative as part of the bo-
vine tuberculosis test, corresponded to an increase in
the prevalence of ELISA positives for JD. The study rec-
ommended that a milk ELISA for JD should be avoided
in the 43-day period following the administration of
purified protein derivative, with serum sampling not rec-
ommended for an additional 28 days. Other studies have
found that co-infection with the helminth Fasciola hep-
atica, which is known to exert an immunoregulatory re-
sponse by down-regulating Th-1 responses in cattle,
may also influence MAP infection. Naranjo-Lucena et al.
(2020) examined the response of bovine immune cells to
MAP using F. hepatica [112]. Although co-infection had
a limited impact on the in vitro immune response of im-
mune cells to MAP, co-stimulation using F. hepatica
molecules appeared to have a measurable effect by redu-
cing responsiveness of bovine monocyte derived macro-
phages ileocaecal lymph node leukocytes to MAP
antigens or infection with MAP. The authors state that
further work would need to be carried out in order to
determine if co-infection would affect the progression of
JD.
Ultimately, it is clear that the specificity and sensitivity
of immunoassays varies and, in their current form, do
not accurately detect MAP infected animals. Identifica-
tion of MAP infection through changes in the microbial
profile may lead to improved prognostics and
diagnostics.
The microbiome and MAP
Among the important roles of the microbiome is the
regulation of the immune system [113–116]. Commensal
microbes can regulate the immune response in
eukaryotic hosts by inducing the inflammatory cascade
via the nuclear factor- kappaB pathway (NF-κB) [117].
NF-κB is a key transcriptional factor controlling the ex-
pression of genes mediating inflammatory and anti-
apoptotic responses. NF-κB is activated by toll-like re-
ceptors (TLRs), a class of membrane receptors that sense
extracellular microbes through recognition of microbial
products, trigger anti-pathogenic signalling cascades in
intestinal epithelial cells and mucosal immune cells.
TLR2, 4 and 9 are believed to play a critical role in the
initiation of immune responses against mycobacteria
[118]. TLRs are essential for the recruitment of immune
cells and the initiation of adaptive immunity in other
Mycobacterial diseases and can also be seen in mouse
models [119].
Although not extensively researched, the microbiome
of animals infected with MAP has been examined, al-
though no consistent pattern has yet emerged. One such
study of dairy calves showed an over-representation of
the families Planococcaceae and Paraprevotellaceae and
an underrepresentation of the genera Faecalibacterium
and Akkermansia in the faecal microbiota of infected
cattle [120]. The group also noted an enrichment of ly-
sine and histidine metabolic pathways and an underrep-
resentation of glutathione metabolism and leucine and
isoleucine degradation pathways within the ileal
mucosa-associated microbiome of the MAP-infected cat-
tle. Another study reported greater proportions of the
genus Psychrobacter and reductions in the proportions
of the genera Oscillospira, Ruminococcus and Bifidobac-
terium in cows infected with MAP [121], while in yet an-
other [122], an altered fecal microbiota in cattle infected
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with MAP was also noted. More specifically, it was
found that MAP positive animals had a higher abun-
dance of Arthrobacter (from Actinobacteria) and Proteo-
bacteria, Alistipes, Paraprevotella and Bacteroides were
reduced in abundance compared to MAP negative ani-
mals. In the MAP negative animals Firmicutes, Clostrid-
ium and Ruminococcus showed low abundance whereas
Bacillus and Enterococcus, that were highly abundant in
the positive group, had decreased. Notably, in this study,
MAP positive animals had a microbiota comprised of a
30% relative abundance of Actinobacteria while negative
animals had just 0.1–0.2% abundance.
Ultimately, a more in depth analysis of the micro-
biomes of MAP positive relative to MAP negative ani-
mals, using shotgun sequencing to classify to species, or
even strain, level may be pivotal in identifying
microbiome-associated contributions to health and dis-
ease in the context of MAP. Importantly, the commen-
sals within the gut microbiome can play an important
role in the control of pathogens through the direct im-
pact on the pathogens and/or the stimulation of host
immunity. The impact of the microbiome on infection
of animals with shiga toxin producing E. coli O157:H7
highlights this point [123], where groups of colonic bac-
teria were associated with pathogen shedding. Gamage
et al. [124] reported that commensal bacteria influence
E. coli O157:H7 persistence and shiga toxin production
in the mouse intestine. Other examples include animals
infected with Campylobacter jejuni [125], which shows
similar changes to the microbiomes of animals infected
with MAP, predominantly differences in Actinobacteria
and Bacteriodetes (which are more abundant in infected
animals relative to non-infected controls). It is not yet
clear if the gut microbiota of ruminants has a role in
preventing or contributing to MAP infection but, should
such a role be established, there are multiple ways in
which this knowledge could be applied. In particular, the
investigation of potential interactions between the gut
microbiota and MAP can be revealed through the use of
carefully designed infection models.
Other –omics based approaches are also relevant.
Metabolic profiling or metabolomics involves the identi-
fication and quantification of numerous low molecular
weight compounds in biological fluid samples [126]. De
Buck et al. [126] showed there was a significant increase
over time in the metabolites allantoin, creatine, isobuty-
rate and tryptophan in MAP infected group, while acet-
one, isopropanol, glucose and myo-inositol decreased.
This was the first study of its kind, with the aim of using
individual metabolites or metabolic profiles as a novel
early detection method for JD. The study showed that
metabolic profiling detected changes associated with
MAP infection quicker than diagnostics available at the
time. Metabolomic profiling has also been used in humans
suffering from IBD, ulcerative colitis and other gastro-
intestinal diseases with promising results [127–129].
The use of microRNAs (short, non-coding RNAs that
regulate mRNA expression) also has the potential to be
used as prognostic or diagnostic biomarkers for numer-
ous human pathologies [130]. Fecal miRNAs can influ-
ence the composition of the microbiome and the
microbiome can influence host physiology by affecting
gene expression in host cells [131]. In a recent study by
Shaughnessy et al. (2020), evidence of differential
miRNA abundance in clinically affected versus healthy
animals was observed [132].
The gut microbiota has also been shown to be influ-
enced by host genetics. Many traits, such as carcass
quality and milk yield, are associated with quantitative
trait loci (QTL) or single nucleotide polymorphisms
(SNPs). Several studies have identified loci associated
with susceptibility to MAP infection. In a study by Kiser
et al. (2017), three popular dairy breeds were examined
for SNP associations with susceptibility to MAP tissue
infection using allelic, additive, dominance and recessive
genome wide association analysis models and 16 new
quantitative trait loci were found in Jersey and Holstein
populations [133]. In a more recent study by McGovern
et al. (2019), it was found that genetic variation in Hol-
stein Friesian in humoral response to MAP infection
was present [134]. The idea of breeding for favourable
traits such as higher milk yields and growth rates are not
a foreign idea in livestock production. However, select-
ing for disease-resistant animals is somewhat novel and
may prevent the contraction of MAP [134]. Being a
member of the Mycobacterium avium complex, MAP is
difficult to treat with antibiotics. A thick waxy cell wall
means MAP cannot be penetrated by cell wall targeting
antibiotics. Therapeutic agents such as penicillins, van-
comycins and cephalosporins are rendered inadequate as
they target peptidoglycan biosynthesis. In fact, the use of
such therapeutic agents may confer antibiotic resistance
and alter the gut microbiota, potentially further contrib-
uting to the disease and susceptibility to other diseases.
Antimicrobial combinations are used to treat and delay
onset of the disease, consisting of macrolide protein syn-
thesis inhibitors such as clarithromycin and azithromy-
cin combined with ethambutol. These agents affect cell
metabolism along with rifamycin which inhibits RNA
synthesis [135]. As JD is a slow onset disease with many
stages before the animal becomes clinical, it can often be
mistaken for other infections, and susceptibility to other
infections, leading to the treatment with ineffective
antibiotics.
The gut microbiome is thought to have a considerable
impact on human and animal health [117, 136–139],
and research in this area has led to the identification of
novel microbiome biomarkers for disease [120, 140,
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141]. There has also been a renewed focus on manipula-
tion of the microbiome through diet or the provision of
microbes as probiotics or biotherapeutics for disease
control. Defining a core healthy microbiome can prove
difficult as many different factors can play a role in shap-
ing the microbiome. Diet, for example, plays a pivotal
role in shaping the gut microbiota [142–144], with many
different feeding systems (high-grain diets versus grass-
based systems) applied worldwide. Animal husbandry
practices (indoor versus outdoor systems) and environ-
mental stresses [145] may also be important. All of the
above parameters are applicable in both healthy and dis-
eased animals. It is also noteworthy that the metabolic
functions of the microbiome also vary across healthy
and diseases states, therefore potentially providing add-
itional biomarkers.
The point is frequently made that hosts have co-
evolved with the gut microbiome in order to achieve sta-
bility, thereby creating “superorganisms”, in which the
microbiome performs many immune, metabolic and
other functions [146]. The composition and function of
the livestock gut microbiome has been extensively inves-
tigated in recent years, with a large focus on the bovine/
ovine rumen microbiome from the perspective of me-
thane mitigation strategies, improved feed utilisation and
overall health and production performance. The rumen
is the forestomach of ruminants and is a large anaerobic,
methanogenic fermentation chamber responsible for
providing nutrients to the host animal, contributing to
end-product yield and quality. Dietary changes can result
in a shift in microbiome composition and diversity, af-
fecting the levels of volatile fatty acids (VFAs) produced
by microbes. VFAs are the product of a series of fermen-
tation reactions and are the primary source of energy for
ruminants. VFAs such as acetate, propionate and butyr-
ate are produced by bacteria. Their ratios influence feed
efficiency, animal health and enteric methane emissions
and have been the focus of extensive examination from
the perspective of the rumen microbiome [147–151].
Butyrate, the main energy source for epithelial cells in
the gut, in particular, plays an important role in host
physiology and gut health, interacting with the immune
system and providing anti-inflammatory effects in
humans [152, 153]. Indeed, a reduced abundance of bu-
tyrate producing species such as Faecalibacterium
prausnitzii, Ruminococcus spp. and Eubacterium spp. has
been observed in patients with CD [21], and have the
potential to serve as non-invasive faecal biomarkers.
VFAs may also have potential with respect to MAP de-
tection and JD, however, more research is needed in this
area.
The post-ruminal digestive tract is also of considerable
importance, particularly with respect to gastrointestinal
diseases, but research in this area is relatively less
advanced. The microbial composition of the post-
ruminal digestive tract depends largely on pH, gut motil-
ity, redox potential and host secretions within the differ-
ent compartments [154]. Significant differences have
been noted between the microbiome of the small intes-
tine (duodenum, jejunum and ileum) and the large intes-
tine (cecum, colon and rectum) [155] and data also
indicates that luminal and mucosa associated communi-
ties also differ among regions and may influence shed-
ding patterns of pathogens such as E. coli [156, 157].
With this in mind, sampling methods may also produce
variable results. This may include differences in collect-
ing samples directly from the rectum, making contact
with the mucosa or a free-fall sample which will be ex-
posed to the external environment. Sampling at nec-
ropsy, which would allow access to multiple sites along
the GIT, would be representative of particular site,
allowing accurate comparisons. The post-ruminal digest-
ive tract is composed mainly of bacteria, however meth-
anogenic archaea have also been observed [155, 158,
159]. Figure 2 illustrates a typical microbiome project
workflow, from sample collection through to data ana-
lysis and interpretation. Employing high throughput
DNA sequencing techniques enables the detection of
specific microbes and functional genes associated with
healthy or diseased states, including the use of micro-
biome signatures as biomarkers, at different locations in
the gastrointestinal tracts of ruminants.
Potential future directions
Changes in the gut microbiome can be associated with
disturbed gut barrier function and increased gut perme-
ability [153]. Therefore, inducing the colonisation of
protective bacteria may have a role in protecting against
MAP-induced gut inflammation. Direct fed microbials,
i.e. probiotics, have the potential to be used as a novel
treatment for JD. In a study by Karunasena et al., (2013),
the use of Lactobacillus animalis NP-51 was examined
for its effect on animal health in an in vivo murine
model infected with MAP. It was found that the pro-
biotic reduced the production of cytokines associated
with the increased stimulation of macrophage [161].
This may be a direct effect of the probiotic or be medi-
ated through the microbiota. Indeed, it was notable that
a positive correlation was identified between the gut
microbiota composition and the aforementioned host
immune responses. More specifically, it was found that,
in untreated mice, the phylum Bacterioidetes correlated
with an interferon gamma response and Proteobacteria
correlated with levels of interleukin 6. Although intri-
guing, much more research is needed in this area. The
identification and growth of novel biotherapeutic strains
that inversely correlate with MAP levels or disease status
may be used for prevention or treatment. Lactic acid
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bacteria, with species belonging to several genera includ-
ing Lactobacillus, Lactococcus, Enterococcus, Pediococcus,
Streptococcus, and Leuconostoc offer promise to finding
the most suitable and beneficial microbes for livestock
[162]. Isolating and growing these microbes may prove
difficult due to their high dependence on a culmination
of specific environmental niches, which may only be
found in the gut. Direct inoculation of an entire faecal
microbiome, through faecal microbiota transplant, may
offer another means.
Feacal microbiota transplantation (FMT) is another,
more extreme, option. The method is effective in treat-
ing disease as it increases microbial diversity, increases
the prevalence of beneficial microbes and aids in restor-
ing a normal microbiome, which may be able to modu-
late immune response. The beneficial microbes that are
re-introduced may outcompete pathogens through com-
petitive exclusion [163]. The procedure has been used to
treat Clostridium difficile infections in humans, when all
other methods have been exhausted. The method has
proved highly successful in clearing infection. FMTs are
received from healthy donors which are then used to
treat C. difficile infection. Brown et al. [164] investigated
the microbial community dynamics and metabolic
changes associated with successful FMT, finding the
microbiome of C. difficile patients became more similar
to the microbiome of the healthy donors. Similarly,
transfaunation is a method used in ruminants to re-
establish or alter the microbiome in the rumen, where
rumen contents is used rather than faeces. Rumen con-
tents is taken from one healthy animal and transferred
into an unhealthy animal. Historically, it has been used
to treat digestive issues, but more recently has been used
to examine feed efficiency [165]. Previously, it was found
that the rumen microbiome was host specific, with the
rumen returning to its original state following transfau-
nation [166]. Zhou et al. [165] found that certain bacter-
ial phylotypes, namely Lactobacillus, Coriobacteriaceae
and Coprococcus may have higher manipulation poten-
tial by means of content transfaunation, however, overall
the microbiome remained host specific. Ribeiro et al.
[167], found that two separate inoculations of rumen
contents from bison to cattle was successful in altering
the microbiome across time. In a comprehensive review
by Niederwerder, (2018) the use of FMT in veterinary
medicine was examined and broken into three potential
applications; therapeutic use, prophylactic use and for
stimulating pathogen-specific immunity and was exam-
ined for both ruminants and monogastrics. The area is
currently in its infancy in veterinary medicine but may
be an emerging prophylactic tool for use in the fight
against JD.
As previously described by Barkema et al. [42], the ef-
fect of MAP genotype on disease progression, shedding
and immune responses is not well characterised. This
may open promising avenues for prognosis following
Fig. 2 Microbiome project workflow for determining the microbiome associated with JD susceptibility or resistance (Adapted from Matthews
et al. [160])
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further investigation. Analysis of volatile organic com-
pounds produced during culture may assist in identify-
ing growth and also strain identification [168]. This may
include the use of methods more traditionally used for
methane detection in ruminants during greenhouse gas
emission studies should specific gaseous emissions asso-
ciated with MAP infection be identified.
Emerging technologies such as biosensors, mobile
phone applications and satellite data may provide novel
methods for disease detection and control in the coming
years. On-farm disease detection may be applicable
using portable sequencing devices such as Oxford Nano-
pore’s MinION. McCabe et al. [169] used the technology
for on farm detection of viral pathogens associated with
bovine respiratory diseases. The authors describe the de-
vice as a Mk1B is a pocket-sized (105 mm × 23mm ×
3384 mm, 87 g) field-deployable sequencing device that
is based on nanopore sequencing, mentioned earlier in
this review. Rapid extraction and sequencing kits would
need to be optimised for the detection of MAP using
these kits. Mobile apps can be used to connect farmers,
veterinary practitioners and scientists. One such app,
EMPRES Global Animal Disease Information system has
been designed to assist veterinary services by facilitating
regional and global disease information. The tool has
contributed to a better understanding of influenza epi-
demiology and ecology in livestock [170]. Developing a
similar tool for JD control, where parameters including,
but not limited to, host genetic data, mode of birth of
animal, microbiome data, MAP isolate data, on farm soil
chemistry, composition and soil microbiome compos-
ition and sward type may contribute to a better under-
standing of disease susceptibility, resistance and
transmission. This would require a multi-disciplinary ap-
proach in order to create such a database. The Big Data
approach to animal health and welfare, using computer
modelling and statistical techniques, will improve wel-
fare, production and sustainability, contributing to a
planetary health strategy to reduce the threat of infec-
tious disease, minimise environmental footprint and pro-
mote nutrition [171].
Conclusions
MAP was first reported to cause JD in ruminants in the
late 1800s. At that point it was described as intestinal tu-
berculosis and known as pseudotuberculous enteritis.
Since then, the understanding of the disease has grown
immensely, with the bacteria causing the disease having
been the subject of detailed genomic analysis. In parallel,
our appreciation of the role of the gut microbiome in
human and animal health has advanced considerably.
Understanding its role in complex gastrointestinal dis-
eases, such as JD, could lead to preventative measures
and the development of novel therapeutic agents such as
probiotics. Dietary interventions may also play an im-
portant role in minimising the detrimental effects on the
animal. While the microbiome of MAP infected animals
is understudied, it has the potential of contributing enor-
mously to the understanding of this complex disease, as
has recently been seen with human microbiome studies
on human disease. Using the knowledge achieved from
such studies may provide a foundation to work off,
building on that knowledge to advance the understand-
ing of complex gut disorders.
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